How does the immune system influence the development and progression of brain tumors, and what new treatment possibilities does immunotherapy offer? These questions were among the topics addressed in a lecture by Magdalena Houdová Megová from the NICR, delivered as part of the Brain Awareness Week festival and attended by dozens of members of the public.

How has our understanding of T-lymphocyte development and T-cell receptor signaling evolved over the past two decades? And what do these advances mean for contemporary immunology and the future of targeted therapies? These and other questions will be addressed by leading molecular immunologist Jonathan S. Duke-Cohan.